Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)
Clinical trial NCT02626884 · COMPLETED
Trial details
- NCT number
- NCT02626884
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.